158 related articles for article (PubMed ID: 20065922)
1. Management of daily headache unresponsive to preventive treatment: daily triptans versus daily opioids.
Piekos K; Spierings EL
Rev Neurol Dis; 2009; 6(4):E121-30. PubMed ID: 20065922
[TBL] [Abstract][Full Text] [Related]
2. Similarities and differences between chronic migraine and episodic migraine.
Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E
Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496
[TBL] [Abstract][Full Text] [Related]
3. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience.
Stillman MJ; Zajac D; Rybicki LA
Headache; 2004 Jan; 44(1):65-9. PubMed ID: 14979885
[TBL] [Abstract][Full Text] [Related]
4. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series.
Landy SH
Headache; 2004 Sep; 44(8):762-6. PubMed ID: 15330821
[TBL] [Abstract][Full Text] [Related]
5. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive inpatient treatment of refractory chronic daily headache.
Lake AE; Saper JR; Hamel RL
Headache; 2009 Apr; 49(4):555-62. PubMed ID: 19245391
[TBL] [Abstract][Full Text] [Related]
7. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
Bigal ME; Serrano D; Reed M; Lipton RB
Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
[TBL] [Abstract][Full Text] [Related]
8. Mexiletine for refractory chronic daily headache: a report of nine cases.
Marmura MJ; Passero FC; Young WB
Headache; 2008; 48(10):1506-10. PubMed ID: 18793209
[TBL] [Abstract][Full Text] [Related]
9. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
[TBL] [Abstract][Full Text] [Related]
10. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
[TBL] [Abstract][Full Text] [Related]
11. Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the frequent headache epidemiology study.
Scher AI; Lipton RB; Stewart WF; Bigal M
Cephalalgia; 2010 Mar; 30(3):321-8. PubMed ID: 19614708
[TBL] [Abstract][Full Text] [Related]
12. Treatment of sinus headache as migraine: the diagnostic utility of triptans.
Kari E; DelGaudio JM
Laryngoscope; 2008 Dec; 118(12):2235-9. PubMed ID: 18948830
[TBL] [Abstract][Full Text] [Related]
13. [Management of chronic daily headache in children and adolescents].
Cuvellier JC
Rev Neurol (Paris); 2009; 165(6-7):521-31. PubMed ID: 19041108
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced refractory headache.
Ward TN
Headache; 2008 May; 48(5):728; discussion 729. PubMed ID: 18471123
[TBL] [Abstract][Full Text] [Related]
15. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines.
Saper JR; Lake AE
Headache; 2008 Jun; 48(6):838-49. PubMed ID: 18549361
[TBL] [Abstract][Full Text] [Related]
16. [Migraine or headache management: a pharmacy survey].
Desamericq G; Revol A; Laforest L; Chamba G; Bauguil G; Ritleng C; Van Ganse E
Therapie; 2009; 64(6):395-403. PubMed ID: 20025843
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
[TBL] [Abstract][Full Text] [Related]
18. The acute treatment of episodic and chronic migraine in the USA.
Bigal ME; Borucho S; Serrano D; Lipton RB
Cephalalgia; 2009 Aug; 29(8):891-7. PubMed ID: 19222509
[TBL] [Abstract][Full Text] [Related]
19. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.
Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P
Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916
[TBL] [Abstract][Full Text] [Related]
20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
